Walgreens Boots Alliance, Inc. (WBA) Stock Price: $11.98+0.00 (+0.00%)
At close: Aug 28, 2025, 4:00 PM ET
The closing share price for Walgreens Boots Alliance, Inc. (WBA) stock was $11.98 for Thursday, August 28, 2025, up 0.00% on the day.
Longer view (total return, dividends reinvested): past 12 months +31.4% · 3-year avg -26.9%/yr · 5-year avg -17.0%/yr
WBA Price Chart
WBA is featured in
WBA Key Metrics
See All MetricsWBA Earnings Preview
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$0.39
vs Estimate
$0.27
Revenue
$38.99B
vs Estimate
$38.25B
WBA Analyst Ratings
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$11.98
High
N/A
WBA Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q4 2025 | $0.43 | $0.43 | $0.43 | 1 |
| Q1 2026 | $0.56 | $0.56 | $0.56 | 1 |
| Q2 2026 | $0.33 | $0.33 | $0.33 | 1 |
| Q3 2026 | $0.24 | $0.24 | $0.24 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.13 | $1.57 | $1.73 | 5 |
| FY 2027 | $-0.37 | $1.67 | $2.78 | 3 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q4 2025 | $36.88B | $39.26B | $41.63B | 2 |
| Q1 2026 | $38.86B | $38.86B | $38.86B | 1 |
| Q2 2026 | $39.04B | $39.04B | $39.04B | 1 |
| Q3 2026 | $37.71B | $37.71B | $37.71B | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $146.86B | $155.99B | $162.14B | 7 |
| FY 2027 | $157.32B | $158.48B | $159.64B | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
Related Stocks
HealthcareWBA Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1WBA | $10.37B | $11.98 | +0.00% | +31.43% | -16.99% | -14.92% | — |
| 2BAX | $10.77B | $20.86 | +1.81% | -32.94% | -22.43% | -5.83% | vs WBA |
| 3CRL | $9.03B | $187.51 | -0.29% | +23.47% | -11.83% | +8.26% | vs WBA |
| 4TEM | $8.35B | $47.82 | -3.57% | -32.88% | N/A | N/A | vs WBA |
| 5ALGN | $12.52B | $174.84 | -0.95% | -3.77% | -22.14% | +8.29% | vs WBA |
| 6BIO | $7.73B | $285.94 | -2.22% | +23.04% | -13.82% | +6.91% | vs WBA |
WBA Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth